These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36960789)

  • 21. Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update.
    Lucarelli G; Loizzo D; Ferro M; Rutigliano M; Vartolomei MD; Cantiello F; Buonerba C; Di Lorenzo G; Terracciano D; De Cobelli O; Bettocchi C; Ditonno P; Battaglia M
    Expert Rev Mol Diagn; 2019 May; 19(5):377-387. PubMed ID: 30957583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipidomics analysis in drug discovery and development.
    Kostidis S; Sánchez-López E; Giera M
    Curr Opin Chem Biol; 2023 Feb; 72():102256. PubMed ID: 36586190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide promoter methylome of small renal masses.
    Ibragimova I; Slifker MJ; Maradeo ME; Banumathy G; Dulaimi E; Uzzo RG; Cairns P
    PLoS One; 2013; 8(10):e77309. PubMed ID: 24204800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applications of Lipidomics in Tumor Diagnosis and Therapy.
    Wang Y
    Adv Exp Med Biol; 2021; 1316():25-39. PubMed ID: 33740241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipidomics applications for disease biomarker discovery in mammal models.
    Zhao YY; Cheng XL; Lin RC; Wei F
    Biomark Med; 2015; 9(2):153-68. PubMed ID: 25689902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolomics and lipidomics strategies in modern drug discovery and development.
    Astarita G; Kelly RS; Lasky-Su J
    Drug Discov Today; 2023 Oct; 28(10):103751. PubMed ID: 37640150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipidomics: Novel insight into the biochemical mechanism of lipid metabolism and dysregulation-associated disease.
    Zhao YY; Miao H; Cheng XL; Wei F
    Chem Biol Interact; 2015 Oct; 240():220-38. PubMed ID: 26358168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urine metabolomics analysis for kidney cancer detection and biomarker discovery.
    Kim K; Aronov P; Zakharkin SO; Anderson D; Perroud B; Thompson IM; Weiss RH
    Mol Cell Proteomics; 2009 Mar; 8(3):558-70. PubMed ID: 19008263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipidomics and Biomarker Discovery in Kidney Disease.
    Afshinnia F; Rajendiran TM; Wernisch S; Soni T; Jadoon A; Karnovsky A; Michailidis G; Pennathur S
    Semin Nephrol; 2018 Mar; 38(2):127-141. PubMed ID: 29602396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipidomics: quest for molecular lipid biomarkers in cardiovascular disease.
    Hinterwirth H; Stegemann C; Mayr M
    Circ Cardiovasc Genet; 2014 Dec; 7(6):941-54. PubMed ID: 25516624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lipidomic profile of the tumoral periprostatic adipose tissue reveals alterations in tumor cell's metabolic crosstalk.
    Altuna-Coy A; Ruiz-Plazas X; Sánchez-Martin S; Ascaso-Til H; Prados-Saavedra M; Alves-Santiago M; Bernal-Escoté X; Segarra-Tomás J; R Chacón M
    BMC Med; 2022 Aug; 20(1):255. PubMed ID: 35978404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frontiers in clinical and molecular diagnostics and staging of metastatic clear cell renal cell carcinoma.
    Czarnecka AM; Kornakiewicz A; Kukwa W; Szczylik C
    Future Oncol; 2014 May; 10(6):1095-111. PubMed ID: 24941992
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S
    DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in lipidomics for disease research.
    Yang L; Li M; Shan Y; Shen S; Bai Y; Liu H
    J Sep Sci; 2016 Jan; 39(1):38-50. PubMed ID: 26394722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive Metabolomics and Lipidomics Profiling of Prostate Cancer Tissue Reveals Metabolic Dysregulations Associated with Disease Development.
    Lima AR; Carvalho M; Aveiro SS; Melo T; Domingues MR; Macedo-Silva C; Coimbra N; Jerónimo C; Henrique R; Bastos ML; Guedes de Pinho P; Pinto J
    J Proteome Res; 2022 Mar; 21(3):727-739. PubMed ID: 34813334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma.
    Wang J; Chang H; Su M; Qiao Y; Sun H; Zhao Y; Zhang S; Shan C
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Standardizing and increasing the utility of lipidomics: a look to the next decade.
    Wang Y; Yutuc E; Griffiths WJ
    Expert Rev Proteomics; 2020 Oct; 17(10):699-717. PubMed ID: 33191815
    [No Abstract]   [Full Text] [Related]  

  • 38. The proteomic landscape of renal tumors.
    Chinello C; L'imperio V; Stella M; Smith AJ; Bovo G; Grasso A; Grasso M; Raimondo F; Pitto M; Pagni F; Magni F
    Expert Rev Proteomics; 2016 Dec; 13(12):1103-1120. PubMed ID: 27748142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma.
    Giribaldi G; Barbero G; Mandili G; Daniele L; Khadjavi A; Notarpietro A; Ulliers D; Prato M; Minero VG; Battaglia A; Allasia M; Bosio A; Sapino A; Gontero P; Frea B; Fontana D; Destefanis P
    J Proteomics; 2013 Oct; 91():385-92. PubMed ID: 23916412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipidomics, Biomarkers, and Schizophrenia: A Current Perspective.
    Sethi S; Hayashi MA; Barbosa BS; Pontes JG; Tasic L; Brietzke E
    Adv Exp Med Biol; 2017; 965():265-290. PubMed ID: 28132184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.